Table 1.

Patient characteristics in epidemiologic wk 3 of 2017–2020, among all patients with ESKD, stratified by kidney replacement therapy, and among patients on dialysis with Medicare coverage, stratified by dialysis modality

Characteristic	All Patients with ESKD				Patients on Dialysis with Medicare Coverage
	Dialysis		Transplant		HD		PD
	2017–2019	2020	2017–2019	2020	2017–2019	2020	2017–2019	2020
Sample size (n)	537,379	568,533	218,713	237,746	287,459	280,433	28,622	30,695
Age, yr (%)
18–44	12.2	11.7	21.3	20.7	10.5	10.2	16.3	15.3
45–64	41.0	40.0	49.6	48.4	39.9	39.4	40.9	39.6
65–74	25.9	26.6	22.2	23.4	27.4	28.0	26.3	27.3
≥75	21.0	21.7	6.9	7.6	22.2	22.4	16.5	17.9
Race/ethnicity
Non-Hispanic White	38.8	38.8	48.7	48.0	40.2	40.9	54.5	55.0
Non-Hispanic Black	32.5	31.9	19.7	20.2	35.3	34.9	23.9	23.3
Hispanic	18.6	19.3	14.1	14.8	15.3	15.5	12.9	13.3
Asian	4.7	5.0	4.6	4.9	4.0	4.2	5.7	5.7
Other/unknown	5.5	5.1	12.9	12.1	5.2	4.6	3.0	2.8
Sex
Female	42.7	42.2	40.5	40.6	44.1	43.5	45.4	44.8
Male	57.3	57.8	59.5	59.4	55.9	56.5	54.6	55.2

Statistics in 2017–2019 columns reflect means of corresponding statistics in epidemiologic wk 3 of 2017, 2018, and 2019.